Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


25th World Congress on Cancer Science and Therapy

Baltimore, USA

Kamala K Maddali

Kamala K Maddali

Cancer Genetics Inc, USA

Title: Integrated biomarker strategies in immuno-oncology


Biography: Kamala K Maddali


Immunotherapy enables the immune system to recognize tumors; insights into immunotherapy biomarker testing, especially PD-L1 IHC and; choosing the best patients for immunotherapy with the use of integrated biomarker panels. Combination regimens of immuno-oncology agents and targeted drugs may represent the next generation of cancer treatments and could result in improved outcomes and prolonged patient survival. This talk will focus on immunooncology advancements and a review of latest drug targets. In addition to the underlying science, we will focus on the practical aspects of targeting the PD1:PD-L1 interaction. We will discuss our perspectives of supporting PD-L1 as a pharmacodynamic end point and companion diagnostic. Additionally, we will focus on case studies, where we monitored PD-L1 expression and the variable sensitivity, specificity and dynamic range of three anti-PD-L1 antibodies in a cohort of 52 primary DLBCL patients. CGI believes that this work is essential in developing durable and reliable immune biomarkers and companion diagnostics for selecting lymphoma patients most likely to benefit from immune-checkpoint therapy.